Group Overview

In July 1981, following a decision by the CPC Shanghai Municipal Committee and the Shanghai Municipal People's Government, Shanghai Industrial Co., Ltd. was registered in Hong Kong, China based on three national industries: Nanyang Brothers Tobacco Co. Ltd. (NBT), The Wing Fat Printing Co., Ltd., and The Tien Chu (Hong Kong) Company Limited. This company operates as a representative firm for the Shanghai Municipal People's Government. In June 1993, it was renamed Shanghai Industrial Investment (Holdings) Co., Ltd. (SIIC).

For over 40 years, under the strong leadership of the CPC Shanghai Municipal Committee and the municipal government, along with the support from all sectors in Hong Kong, SIIC has consistently aligned with national strategies, supported Shanghai's development, and facilitated cooperation between Shanghai and Hong Kong. Established in the context of China's opening-up, growing through collaboration, and moving forward through innovation, the company has made a distinctive contribution by introducing foreign technology, capital, and advanced management practices to Shanghai, expediting urban development and social progress, advancing the reform of state-owned enterprises (SOE), nurturing global talent, and fostering collaboration between Shanghai and Hong Kong. Today, it stands as one of the most locally representative Chinese enterprises in Hong Kong. In 2021, Carrie Lam Cheng Yuet-ngor, the then Chief Executive of the Hong Kong Special Administrative Region, sent a congratulatory message to SIIC on the occasion of its 40th anniversary, praising the company for its deep-rooted contributions and distinguished reputation, and acknowledging its positive efforts towards Hong Kong's prosperity, stability, and the exchanges between Shanghai and Hong Kong. In 2023, SIIC recorded a revenue of HKD322.1 billion, a total profit of HKD16.4 billion, and total assets amounting to HKD496.5 billion, ranking among the top in key performance metrics within Shanghai's state-owned assets system.

As the largest actively managed investment holding group of Shanghai State-owned Assets Supervision and Administration Commission (SASAC), SIIC capitalizes on its cross-border advantages and exceptional capabilities in capital operations and industrial management, with total investments exceeding HKD100 billion over the years. Historically, it has held stakes in a multitude of influential publicly listed companies, including Haitong Securities, Semiconductor Manufacturing International Corporation (SMIC), Bright Dairy & Food Co., Ltd. (Bright Dairy & Food), Shanghai Jahwa United Co., Ltd., and Lianhua Supermarket Holdings Co., Ltd., pioneering many industry firsts and gaining a solid reputation along with widespread acknowledgment.

At present, SIIC is mainly engaged in business sectors including life and health, environmental health, urban renewal, financial investments, and low-carbon consumption. The company owns five publicly listed subsidiaries in Shanghai, Hong Kong, and Singapore: Shanghai Industrial Holdings Limited (00363.HK), Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH/02607.HK),  SIIC Environment Holdings Ltd. (BHK.SG/00807.HK), Shanghai Industrial Development Co., Ltd. (600748.SH), and Shanghai Industrial Urban Development Group Co. Ltd.(00563.HK). Additionally, the company has established and manages two major municipal funds: Shanghai Healthcare Capital (SHC) and Shanghai Capital of Culture Industry ; it holds a controlling stake in Tianjin Trust Co., Ltd.and invests in Tianjin Pharmaceutical Holdings Co., Ltd., with more than 1,000 member enterprises and over 69,000 employees. SIIC has a fully integrated industrial chain in its life and health business that includes manufacturing, R&D, distribution, and retail. It ranks ranks among the top three in the country in terms of overall strength, successfully implementing an integrated approach to development that incorporates industry, commerce, research, and investment. Since 2020, Shanghai Pharma has been listed in the Fortune Global 500 and among the top 50 global pharmaceutical companies for five consecutive years. In the environmental health sector, the water services business boasts a total daily processing capacity of 22 million tons, placing SIIC among the top three in the country and the top six globally. SIIC owns three toll roads in Shanghai including Jing-Hu Expressway (Shanghai Section), Hu-Kun Expressway (Shanghai Section), Hu-Yu Expressway (Shanghai Section) and 23.06% stake of the Hangzhou Bay Bridge. Furthermore, the installed capacity for photovoltaic power is 740 MW, and for wind power projects, it is 769 MW. SIIC is on track with the planned development of several key projects, including the 480-meter tallest building on the North Bund waterfront (Lot 91) in Hongkou District in Puxi, the Shanghai Biopharmaceutical Innovation Center (No. 88 Zhangjiang Road), the widening and alternation project for the G50 Shanghai-Chognqing expressway (Shanghai section), and the PPP project of Shanghai Xicen water purification plant in Qingpu District. As Shanghai's first major municipal project for the integrated processing of dry and wet household waste after the city's waste sorting initiative, Shanghai Baoshan Renewable Energy Utilization Center was successfully connected to the power grid in September 2022.

With years of experience in international, market-oriented, and specialized capital operations, SIIC has established a talented workforce familiar with the rules of both international and domestic markets. This team, equipped with a global perspective and professional capabilities in capital operations and industrial management, is essential for ensuring the company's ongoing high-quality development.